In a study by Cornelissen et al., FGF-23 was only predictive for 1-year mortality in AMI patients with heart failure, but not so in AMI patients without heart failure; which indicates an interaction with heart failure and LVEF. This evidence concerns the gene FGF23 and heart failure.